We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In an effort to accelerate drug and diagnostic advances in multiple sclerosis (MS), non-alcoholic fatty liver disease and other conditions, Quest Diagnostics and Decode Health are working on a national platform for gathering and storing trial participant specimens for future RNA analysis. Read More
Sensoria Health and Padula Research Technologies (PRT) will be presenting details of NeurOpTrek and its sock sensor tool to assess the risk of falling at the American Academy of Optometry annual meeting in San Diego, Oct. 26-29. Read More
Pancreatic cancer patients treated with ViewRay’s MRIdian ablative radiation technology had a one-year survival rate from diagnosis of 93.9 percent and no incidences of acute toxicity, according to study results reported at the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Antonio, Texas, Oct. 24-27. Read More
Brooklyn, N.Y.-based FesariusTherapeutics’ DermiSphere dermal scaffold supported a skin graft from full-thickness skin loss more effectively and more quickly in a preclinical study than existing dermal templates, the company’s researchers reported in the peer-reviewed Journal of Tissue Engineering and Regenerative Medicine. Read More
DNA sequencing giant Illumina is teaming up with AstraZeneca to seek out potential new drug targets using Illumina’s genomic analysis artificial intelligence (AI) technology. Read More
OrthoGroup was handed a Form 483 after an inspection of its Rancho Cordova, Calif., facility found incomplete device history records (DHR), missing corrective and preventive action (CAPA) records and multiple procedures not being followed. Read More
Merck KGaA has partnered with French devicemaker Biocorp to create a new version of Biocorp’s Mallya pen injector smart device for delivery of human growth hormone. Read More